Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 58 | Foran Joseph WmDirector, Chairman and CEO | Open-market purchase | BUY | $257K 5,000 sh | Nov 9, 2026 |
| 51 | Travisano Jacqueline ADirector | Open-market purchase | BUY | $98K 530 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 49 | Harrison Street Real Assets Fund LLC10% Owner | Open-market purchase | BUY | $45.20M 1.71M sh | Nov 9, 2026 traded Nov 5, 2026 |
| 48 | Lazar Jack RDirector | Open-market purchase | BUY | $380K 10.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 48 | Appel Shelley FDirector | Open-market purchase | BUY | $24K 475 sh | Nov 9, 2026 traded Nov 9, 2026 |
| 47 | Wilson David J.Director, President & CEO | Open-market purchase | BUY | $281K 16.7K sh | Nov 9, 2026 traded Nov 5, 2026 |
| 47 | Wede ScottDirector | Open-market purchase | BUY | $940K 50.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 46 | Ellingson Alan WayneChief Financial Officer | Open-market purchase | BUY | $350K 18.9K sh | Nov 9, 2026 traded Nov 9, 2026 |
| 44 | Shivaram Sachin MDirector | Open-market purchase | BUY | $50K 5,000 sh | Nov 9, 2026 traded Nov 9, 2026 |
| 44 | Appel Shelley FDirector | Open-market purchase | BUY | $14K 275 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 44 | Appel Shelley FDirector | Open-market purchase | BUY | $30K 600 sh | Nov 9, 2026 traded Nov 9, 2026 |
| 44 | Harvey Paul WDirector | Open-market purchase | BUY | $26K 500 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 44 | Wilson David J.Director, President & CEO | Open-market purchase | BUY | $68K 4,104 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 44 | McAtee David R IIDirector | Open-market purchase | BUY | $197K 2,800 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 44 | Muken RossDirector, Chief Executive Officer | Open-market purchase | BUY | $137K 20.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 43 | Stetson Glenn WEVP and COO | Open-market purchase | BUY | $51K 1,000 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 43 | Szlosek Thomas AEVP & CFO | Open-market purchase | BUY | $100K 540 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 43 | Szlosek Thomas AEVP & CFO | Open-market purchase | BUY | $100K 541 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 41 | Richards PaulSee Remarks | Open-market purchase | BUY | $50K 3,000 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 41 | Goldentree Asset Management Lp10% Owner | NONEKeenova Therapeutics plc Open-market purchase | BUY | $13.01M 145.7K sh | Nov 9, 2026 traded Nov 5, 2026 |
| 40 | Wilson David J.Director, President & CEO | Open-market purchase | BUY | $104K 6,073 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 40 | Franklin Philip GDirector | Open-market purchase | BUY | $310K 5,000 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 40 | Wall William PDirector | Open-market purchase | BUY | $90K 1,000 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 39 | Hamble International Inc.10% Owner | Open-market purchase | BUY | $500K 166.6K sh | Nov 9, 2026 traded Nov 5, 2026 |
| 39 | Hamble International Inc.10% Owner | Open-market purchase | BUY | $500K 166.6K sh | Nov 9, 2026 traded Nov 5, 2026 |
| 39 | Splinter Michael RDirector | Open-market purchase | BUY | $300K 840 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 39 | Bauer Scott TPresident of subsidiary bank | Open-market purchase | BUY | $2,970 88 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 39 | Quaglio Kenneth LDirector | Open-market purchase | BUY | $4,971 520 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 39 | Tannenbaum RobynPresident and CIO | Open-market purchase | BUY | $31K 10.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 39 | Hetzel BrandonCFO and Treasurer | Open-market purchase | BUY | $4,575 1,500 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 37 | Goldentree Asset Management Lp10% Owner | NONEKeenova Therapeutics plc Open-market purchase | BUY | $13.39M 150.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 37 | McGraner MattSee Remarks | Open-market purchase | BUY | $100K 5,910 sh | Nov 9, 2026 traded Nov 5, 2026 |
| 37 | Stark Eugene SDirector | Open-market purchase | BUY | $20K 15.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 36 | Bartels Robert E JrDirector | Open-market purchase | BUY | $117K 1,918 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 36 | Mindlin Damian MiguelVicepresident | Open-market purchase | BUY | $1.29M 20.0K sh | Nov 9, 2026 traded Nov 5, 2026 |
| 36 | Potter LeonardDirector | Open-market purchase | BUY | $115K 20.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 36 | Cooper Arthur S.CEO & President | Open-market purchase | BUY | $100K 9,853 sh | Nov 9, 2026 traded Nov 6, 2026 |
| 35 | Moret Blake D.Director, President and CEO | Open-market purchase | BUY | $401K 1,039 sh | Nov 9, 2026 traded Nov 9, 2026 |
| 35 | Tannenbaum Leonard MDirector, 10% Owner | Open-market purchase | BUY | $57K 18.5K sh | Nov 9, 2026 traded Nov 6, 2026 |
| 35 | Moret Blake D.Director, President and CEO | Open-market purchase | BUY | $932K 2,411 sh | Nov 9, 2026 traded Nov 9, 2026 |